ArticlePloS one2025
Plebeia catamarcensis and Tetragonisca fiebrigi (Hymenoptera, Apidae) propolis promotes longevity and anti-Alzheimer effects in Caenorhabditis elegans.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Geopropolis fromPharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease is a neurodegenerative condition associated with oxidative stress, affecting millions of people worldwide, with expected increases due to the aging population. The development of efficient therapies is still challenging. Propolis, with its antioxidant properties, shows potential in controlling the oxidative stress associated with the disease. The present study aimed to determine the chemical composition of ethanolic extract from propolis produced by Plebeia catamarcensis (EEP-Pc) and Tetragonisca fiebrigi (EEP-Tf), as well as their in vitro and in vivo antioxidant effects, lifespan influence and induced paralysis in Caenorhabditis elegans, mutant model for Alzheimer's disease. The chemical profile of EEP-Pc and EEP-Tf was characterized through GC-MS and HPLC, identifying phenolic compounds and terpenes. In vitro antioxidant activity was observed using the DPPH• free radicals scavenging method and protection against proteins and DNA oxidation. In vivo, P. catamarcensis and T. fiebrigi propolis extracts showed no reproductive or locomotor toxicity and promoted resistance to oxidative stress in nematodes exposed to the oxidative agent Juglone. Both propolis extracts increased longevity and reduced the signs of paralysis caused by the accumulation of β-amyloid peptides, a marker for Alzheimer's disease. Together, these data show that propolis from stingless bees P. catamarcensis and T. fiebrigi exhibits promising antioxidant activities against oxidative stress, indicating pharmacological potential with the capacity to reduce symptoms of Alzheimer's disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.